Cargando…
Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task
Central diabetes insipidus (CDI) is a rare endocrine disease deriving from an insufficient production or secretion of anti-diuretic hormone. Recently, CDI has been reported as a rare side effect triggered by immune checkpoint inhibitors (ICI) in cancer patients. Despite its current rarity, CDI trigg...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978963/ https://www.ncbi.nlm.nih.gov/pubmed/35388297 http://dx.doi.org/10.3389/fendo.2022.840971 |